MedTrace Logo

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

NCT06304233 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-06-22

No results posted yet for this study

Summary

To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.

Conditions

Interventions

DIAGNOSTIC_TEST

Echocardiography

ultrasound assessment of heart structure, volume and function

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance Imaging

MRI assessment of heart structure, volume, function and tissue characteristics

DIAGNOSTIC_TEST

Electrocardiography

Assessment of cardiac rhythm and electrical activity

OTHER

Blood sampling

To measure DISC1 mRNA expression and other potential biomarkers

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Morten A Høydal, PhD · Norwegian University of Science and Technology

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2026-12-31
Completion
2038-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06304233 on ClinicalTrials.gov